In pharmaceutical industries,
pharmaceutical excipients play a major role in formulation development apart
from active ingredients. In many oral products, excipients structure the
majority of the entire dosage form. The use of generic drugs has increased
significantly in recent years across all the countries over the globe with the
rapid progress of the pharmaceutical manufacturing sector, the demand for
drug’s active ingredient and excipients such as diluents, fillers, binders,
disintegrants, lubricants, coloring agents, and preservatives which are
critical and essential components of a modern drug product is expected to
increase over the coming years. Furthermore, with increasing demand for more accessible
medication, the production of generic drugs is anticipated to grow considerably
in developing countries, which is also expected to drive the demand for
inactive excipients, that play a major role in formulation development. Infinium Global Research’s recent report
on the “Pharmaceutical Excipients Market (Type - Organic, and Inorganic;
Functionality - Binders & Fillers, Coating Agents, Disintegrants, Flavoring
Agents and Colorants, Lubricants and Glidants, Sweeteners, Preservatives &
Antioxidants, and others): Global Industry Analysis, Trends, Size, Share and
Forecasts to 2026” provides a comprehensive outline of the factors
responsible for the growth of the market.
The impact of the COVID 19
pandemic on the Global
Pharmaceutical Excipients Market is expected to slightly lower the
consumption of pharmaceutical excipients for the year 2020. Currently, as the
entire health care system is primarily focused on containing and preventing
this virus, an exponential demand of generic drugs such as choloroquine and
hydrochloroquine is witnessed in the global market, however, the production of
several other drugs has been lowered which will result in decreased usage of
pharmaceutical excipients. In addition, severe supply disruptions in the market
due to lockdown in major countries and cross border sealings has also created
an impact on the market. Furthermore, owing to the broken supply chain
management and lesser possibility of receiving excipients from China, this can
be an opportunity to locally manufacture pharmaceutical excipients for several
pharmaceutical manufacturers for medicines and for easier export with less
dependency. However, over the post pandemic period, the market is expected to witness
greater demand owing to rising demand for generic drugs in the market. Infinium
Global Research’s recent report on the Pharmaceutical Excipient market (Type –
Organic & Inorganic; Functionality - Binders & Fillers, Coating Agents,
Disintegrants, Flavoring Agents and Colorants, Lubricants and Glidants,
Sweeteners, Preservatives & Antioxidants, and Others) Global Industry
Analysis, Trends, Size, Share and Forecasts to 2026” provides a comprehensive
outline of the factors responsible for the growth of the market.
https://www.infiniumglobalresearch.com/reports/sample-request/1349
The use of generic drugs has
increased significantly in recent years across all the countries over the
globe. Moreover, in pharmaceutical industries, inactive excipients play a major
role in formulation development apart from active ingredients. They are substances
other than the pharmacologically active drug or prodrug which are included
within the manufacturing process or are contained during a finished
pharmaceutical product dosage form. In many products, excipients structure the
majority of the entire dosage form. Furthermore, with increasing demand for
more accessible medication, the production of generic drugs is anticipated to
grow considerably in developing countries. India ranks 4th in terms of generic
production. As the largest provider of generics in the world, the sector
contributes to 40% of the United States’ generic demand with Indian companies
receiving 304 Abbreviated New Drug Application approvals from the United States
Food and Drug Administration (USFDA) in 2017. Similarly, generic drugs are the
mainstay of China's pharmaceutical industry and are likely to remain so for a
long time. While the government encourages and relies upon innovation to meet
industry targets, China will probably continue to rely upon the widespread
prescription of generics in the public insurance plan to hold down the overall
healthcare expenditures. In recent years, there is an upsurge in pharmaceutical
production through public, private and mixed partnerships, or regional
initiatives for licensing of production for generics to improve access to
affordable medicines even in sub-Saharan Africa. Thus, driving the demand for
pharmaceutical excipients in the developing world markets.
https://www.infiniumglobalresearch.com/reports/enquiry/1349
Geographically, North America
generated the largest revenue in the medical robotic systems market in 2019 and
is expected to continue its dominance over the forecast years. Increasing
incidences of chronic diseases owing to a sedentary lifestyle, hefty
investments by the pharmaceutical companies in the development of medicines,
implementing new novelties like nanotechnology are the major driving forces of
the market. On the other hand, the Asia Pacific region is anticipated to grow
with the fastest CAGR in the pharmaceutical excipient market. Major countries
in the region such as Japan, India, and China are likely to drive the
pharmaceutical excipients market. China is known as a major excipient exporter
in the world, moreover, growing support from government and non-government
organizations to expand pharmaceutical industry is escalating the growth of the
market.
Some of the significant vendors
in the global pharmaceutical excipients market are The Dow Chemical Company,
BASF, Ashland Global Specialty Chemicals Inc., Roquette, Evonik Industries,
Archer Daniels Midland, and many others. Though the increasing demand for
functional excipients will provide immense growth opportunities, the loss of
patents and patent expiry will challenge the growth of the pharmaceutical
excipients market participants. To make the most of the opportunities, market
players should focus more on the growth prospects in the fast-growing segments,
whereas sustaining their positions in the slow-growing segments.